For help on how to get the results you want, see our search tips.
16 results
Categories
Human Remove Human filter
Patient safety
Yes Remove Yes filter
-
List item
Human medicine European public assessment report (EPAR): Pradaxa (updated)
Dabigatran etexilate mesilate, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 17/03/2008,
, Revision: 32, Authorised, Last updated: 19/01/2021
-
List item
Human medicine European public assessment report (EPAR): Gilenya
fingolimod hydrochloride , Multiple Sclerosis
Date of authorisation: 17/03/2011,, 
, Revision: 27, Authorised, Last updated: 18/12/2020
-
List item
Human medicine European public assessment report (EPAR): Xeljanz
tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013,, , Revision: 15, Authorised, Last updated: 14/12/2020
-
List item
Human medicine European public assessment report (EPAR): Eliquis
Apixaban, Arthroplasty, Venous Thromboembolism
Date of authorisation: 18/05/2011,, Revision: 23, Authorised, Last updated: 03/11/2020
-
List item
Human medicine European public assessment report (EPAR): Capecitabine Medac
capecitabine, Colorectal Neoplasms
Date of authorisation: 19/11/2012,, 
, Revision: 10, Authorised, Last updated: 05/08/2020
-
List item
Human medicine European public assessment report (EPAR): Capecitabine Accord
capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012,, , Revision: 12, Authorised, Last updated: 03/08/2020
-
List item
Human medicine European public assessment report (EPAR): Picato
Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012,, , Revision: 10, Withdrawn, Last updated: 31/07/2020
-
List item
Human medicine European public assessment report (EPAR): Ecansya (previously Capecitabine Krka)
capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012,, , Revision: 12, Authorised, Last updated: 31/07/2020
-
List item
Human medicine European public assessment report (EPAR): Teysuno
tegafur, gimeracil, oteracil, Stomach Neoplasms
Date of authorisation: 14/03/2011,, Revision: 18, Authorised, Last updated: 30/07/2020
-
List item
Human medicine European public assessment report (EPAR): Xeloda
capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 02/02/2001,, Revision: 25, Authorised, Last updated: 30/07/2020
-
List item
Human medicine European public assessment report (EPAR): Capecitabine Teva
capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012,, , Revision: 13, Authorised, Last updated: 29/07/2020
-
List item
Human medicine European public assessment report (EPAR): Lemtrada
alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013,, , Revision: 10, Authorised, Last updated: 21/07/2020
-
List item
Human medicine European public assessment report (EPAR): Esmya
ulipristal acetate, Leiomyoma
Date of authorisation: 22/02/2012,, Revision: 15, Suspended, Last updated: 02/04/2020
-
List item
Human medicine European public assessment report (EPAR): Ulipristal Acetate Gedeon Richter
ulipristal acetate, Leiomyosarcoma
Date of authorisation: 27/08/2018,, Suspended, Last updated: 02/04/2020
-
List item
Human medicine European public assessment report (EPAR): Xarelto
rivaroxaban, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 30/09/2008,, , Revision: 32, Authorised, Last updated: 17/01/2020
-
List item
Human medicine European public assessment report (EPAR): Lartruvo
Olaratumab, Sarcoma
Date of authorisation: 09/11/2016,, , 
, 
, Revision: 3, Withdrawn, Last updated: 02/09/2019